NCT01351805View on ClinicalTrials.gov

Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain

NAActive, not recruitingINTERVENTIONAL
Enrollment

25,871

Participants

Timeline

Start Date

July 31, 2010

Primary Completion Date

November 10, 2018

Study Completion Date

February 28, 2025

Conditions
Autoimmune DiseasesSystemic Inflammatory ProcessKnee Pain ChronicOsteoarthritisRheumatoid Arthritis
Interventions
DRUG

Fish Oil

Subjects will receive marine omega-3 fatty acids (465 mg of eicosapentaenoic acid \[EPA\] and 375 mg of docosahexaenoic acid \[DHA\]).

DIETARY_SUPPLEMENT

Vitamin D

Subjects will receive vitamin D3 (cholecalciferol) 2000 IU a day.

OTHER

placebo pill

placebo

Trial Locations (1)

02115

Brigham and Women's Hospital, Boston

All Listed Sponsors
collaborator

National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

NIH

lead

Brigham and Women's Hospital

OTHER

NCT01351805 - Vitamin D and Fish Oil for Autoimmune Disease, Inflammation and Knee Pain | Biotech Hunter | Biotech Hunter